Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.19.1
Note 14 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Revenues $ 10,679,000 $ 8,646,000  
Operating income (loss) 1,048,865 (83,775) $ 143,535
Depreciation and amortization 365,678 387,417  
Bargain purchase gain 19,298  
Other (expense) income, net (116,838) (11,194)  
Loss before income tax benefit (expense) 951,325 (94,969) $ 108,968
Operating Segments [Member]      
Operating income (loss) 3,335,000 2,281,000  
Corporate, Non-Segment [Member]      
Operating income (loss) (2,286,000) (2,365,000)  
Corporate Clinics [Member]      
Revenues 5,639,000 4,805,000  
Operating income (loss) 946,000 466,000  
Depreciation and amortization 313,000 303,000  
Franchise Operations [Member]      
Revenues 5,040,000 3,841,000  
Operating income (loss) 2,389,000 1,815,000  
Depreciation and amortization  
Corporate Segment [Member]      
Depreciation and amortization $ 53,000 $ 84,000